Comments*

 
  • Clinical Medicine

  • Featured Event

    Green Buildings and Health: From the Lab to the Real World

    Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
    The New York Academy of Sciences

    Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.

  • Events 

    June 21 - 22, 2017

    The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?

    Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.

    Tuesday, October 24, 2017 | 9:00 AM - 5:00 PM

    Towards Transformative Therapies for Sickle Cell Disease

    Speakers: Philip D. Gregory (bluebirdbio), Josh Lehrer (Global Blood Therapeutics), Deepa Manwani (The Children's Hospital at Montefiore, Albert Einstein College Of Medicine), Debra Pittman (Pfizer), Andreas Reik (Sangamo BioSciences), Vijay G. Sankaran (Boston Children's Hospital, Harvard Medical School), Wally Smith (Virginia Commonwealth University Medical Center), Kenneth I. Ataga (University of North Carolina at Chapel Hill)

    This symposium will explore recent developments in the field including elucidation of biological mechanisms of disease and cutting-edge clinical science, while underscoring the importance of the patient experience.

  • Past Events

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

    Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

    Gene Therapy for Rare Diseases

    Speakers: Brian Kaspar (AveXis Inc.), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida Powell Gene Therapy Center), Maria Escolar (University of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and Steven J. Gray (University of North Carolina at Chapel Hill)

    Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in the field, and identify ongoing obstacles on the path to wider use of this approach.

    February 27 - 28, 2017

    Frontiers in Cancer Immunotherapy

    Keynote Speaker: Padmanee Sharma (The University of Texas MD Anderson Cancer Center)

    Discover the latest on immunotherapeutic strategies that are currently being employed to treat some of the most devastating forms of cancer from leading experts in immunotherapy.
     
    This event is sold out.

    Friday, October 7, 2016 | 9:00 AM - 5:00 PM

    Advances in the Neurobiology of Mental Illness

    Mental illness causes debilitating consequences on quality of life for individuals, families, and society. This symposium explores avenues for translating these discoveries about the neurobiology of a spectrum of mental illnesses into new treatments.

  • Publications 

    Annals

    Special Issue: The Year in Diabetes and Obesity

    Edited by Rexford Ahima (Johns Hopkins University School of Medicine)

    Scholarly reviews of current topics in diabetes and obesity

    eBriefing

    Advances in the Neurobiology of Mental Illness

    Speakers: Tyrone D. Cannon (Yale University), K. Ranga Rama Krishnan (Rush Medical College), Husseini Manji (Janssen Research & Development, LLC), Vaibhav Narayan (Janssen Research & Development, LLC), Daniel Pine (National Institute of Mental Health, US National Institutes of Mental Health), and B. Timothy Walsh (New York State Psychiatric Institute, Columbia University)

    At this symposium, scientists, physicians, clinicians, other allied healthcare providers, policy makers, and patients explored new scientific understanding of the neurobiology of a range of mental illnesses.

    Annals

    Special Issue: Antimicrobial Therapeutics Reviews

    Edited by Gerald D. Wright (McMaster University)

    Nine scholarly review articles discussing aspects of antibiotic resistance

    eBriefing

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speakers: Barry G. Arnason, MD (University of Chicago) and Giancarlo Comi, MD (Università Vita-Salute San Raffaele)

    This one-day, translational conference brought together academic and clinical researchers with industry leaders to discuss current therapeutics.